Healthcare - Biotechnology - NASDAQ - US
$ 2.21
-12.3 %
$ 271 M
Market Cap
-2.6
P/E
Price Target
Average
35.75%
Revenue Forecast
Estimate
49.50%
EBIT
Estimate
--0.11%
Net Income
Estimate
50.68%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Mersana Therapeutics, Inc.
Wall Street analysts predict an average 1-year price target for MRSN of $3 , with forecasts ranging from a low of $3 to a high of $3 .
MRSN Lowest Price Target
Wall Street Target
3 USD
35.75%
MRSN Average Price Target
Wall Street Target
3 USD
35.75%
MRSN Highest Price Target
Wall Street Target
3 USD
35.75%
REVENUE FORECAST
Revenue Forecast Chart MRSN
EBIT FORECAST
EBIT Forecast Chart MRSN
NET INCOME FORECAST
Net Income Chart MRSN